Amicus Briefing in Amgen v. Sanofi: The Rest of the Story

Start
The Supreme Court’s consideration of the standards for satisfying the enablement provisions of 35 U.S.C. 112(a) has been occasioned for the first time in over a century by the Court’s granting certiorari in Amgen v. Sanofi.  This has not surprisingly generated a great deal of interest and amicus briefing….
By: McDonnell Boehnen Hulbert & Berghoff LLP
Previous Story

CJEU specifies requirements for compensation of non-material damages for breaches of the GDPR

Next Story

Cross-Border Collaborations: Key Pitfalls for Asian Life Sciences Companies and How to Avoid Them